Bertrand et al. partly explained these effects by the observation that TNFα/TNFR1 signaling triggers AICD of tumor-infiltrating CD8+ T cells in melanoma, with subsequent lack of response to anti-PD-1 therapy [126]. The gene discussed is CD8A; the disease is neoplasm.